Key Financial Data Of Group

Daito Pharmaceutical Co., Ltd. - Filing #7611167

Concept 2021-12-01 to
2022-02-28
2021-06-01 to
2022-02-28
As at
2022-02-28
2020-06-01 to
2021-05-31
As at
2021-05-31
As at
2021-02-28
2020-06-01 to
2021-02-28
2020-12-01 to
2021-02-28
Key financial data of group
Business results of group
Net sales
33,583,023,000 JPY
48,714,993,000 JPY
37,835,931,000 JPY
Ordinary profit (loss)
5,794,485,000 JPY
6,067,595,000 JPY
5,422,050,000 JPY
Profit (loss) attributable to owners of parent
3,978,141,000 JPY
4,246,459,000 JPY
3,699,918,000 JPY
Comprehensive income
4,069,784,000 JPY
3,908,520,000 JPY
3,544,965,000 JPY
Net assets
46,304,729,000 JPY
41,917,362,000 JPY
41,553,807,000 JPY
Total assets
62,679,967,000 JPY
57,739,365,000 JPY
59,307,351,000 JPY
Basic earnings (loss) per share
85.76
287.81
311.02
271.39
93.09
Diluted earnings per share
Equity-to-asset ratio
0.733 xbrli:pure
0.721 xbrli:pure
0.695 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.